戻る Agenda
Closing Session
Session Chair(s)
Sara Torgal, MPHARM
Global Regulatory Policy Lead
DIA, Switzerland
A must-attend review of the Conference Insights and Outcomes by the Conference Topic Leads, followed by closing remarks from the SVP and Managing Director of DIA EMEAI.
Speaker(s)
Ania Mitan
DIA, Switzerland
Senior Vice President & Managing Director, DIA EMEA and India
Take 5: Artificial Intelligence, Data Science & RWE
Álmath Spooner, PHD
AbbVie, Ireland
Director of Regulatory Policy and Intelligence
Take 5: Clinical Trials Development & Operations
Marianne Lunzer, DrMed
AGES, Austria
Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care
Take 5: CMC & Product Quality
Matt Popkin, PHD
GSK, United Kingdom
Senior Director, CMC Excellence, Global Regulatory Affairs
Take 5: International Collaboration & Regional Updates
Sara Torgal, MPHARM
DIA, Switzerland
Global Regulatory Policy Lead
Take 5: Medical Devices & Combination Products
Tim Chesworth
Novartis, United Kingdom
Senior Director Regulatory Affairs
Take 5: Pharmacovigilance & Safety
James Whitehead, MBA, MSC
Visiting Lecturer - Pharmacovigilance MSc Course, University of Hertfordshire, United Kingdom
Former Senior Director Device & Digital Safety - AstraZeneca
Take 5: Professional Development
Claudia Ferreira
DIA, Switzerland
Scientific Programs Manager
Take 5: Regulatory Operations
Rodrigo Palacios, MBA
F. Hoffmann-La Roche Ltd., Switzerland
Senior Director, Technical Regulatory Policy
Take 5: Regulatory Strategy & EU Pharmaceutical Policy
Emma Du Four, MBA
Independent, United Kingdom
Independent Regulatory and R&D Policy Professional
Take 5: Value and Access
James Ryan, MSC
AstraZeneca (Global), UK, United Kingdom
Director, Global HTA Policy